Vancomycin Utilization Evaluation in a teaching hospital: A case- series study in Iran.

  • Fanak Fahimi Clinical Pharmacy Department, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran AND Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases (NRITLD), Pharmaceutical Care Department,Tehran,Iran
  • Fatemeh Soleymani Department of Pharm acoeconomics and Pharmaceutical Management, Faculty of Pharmacy, Tehran University of Medical Sciences , Tehran, Iran AND National Committee on Rational Use of Drugs, Food and Drug Organization, Ministry of Health and Medical Education, Tehran, Iran
  • Maria Tavakoli-Ardakani Mail Clinical Pharmacy Department, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran AND Pharmaceutical Science Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Keywords:
Drug Utilization Review, Vancomycin, Prescriptions

Abstract

Background: Increasing antimicrobial resistance is now a critical point of human being in the world. Especially wide spectrum antibiotics resistance germs like vancomycin-resistant enterococci (VRE) should be dealt as soon as possible as an emergency conflict. Our study tries to reveal the amount of irrational use of vancomycin in a teaching hospital in Iran.
Methods: We elected the whole inpatients that received vancomycin between February 2007 and May 2008.
Results: Forty four out of those 45 patients had inappropriate indication and dosing regimen of vancomycin (97.7%). The most use of vancomycin was recorded in hematology – oncology ward and then Intensive Care Unit (ICU). Culture responses were negative despite great clinical evidence of infection.
Conclusion: Vancomycin irrational use was high compared to other countries and it could be concerned as a major health problem by health policy makers and physicians to deal. However more detailed researches are needed to reveal the other aspects of this problem. Implementation of antibiotic protocols and standard treatment guidelines are recommended.

References

Kalvin M, Kunin MD. Resistance to antimicrobial drugs: A Worldwide Calamity. Ann Intern Med 1993; 118(7): 557-61.

BMJ-British Medical Journal (2008, September 18). World Faces Global Pandemic Of Antibiotic Resistance, Experts Warn. Science Daily. Retrieved January 13, 2009, from http://www.sciencedaily.com/ releases/2008/09/080918192836.htm

U.S. Department of health and human services. Recommendations for Preventing the Spread of Vancomycin Resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). MMWR recommendations and reports. (1995 September 22) 44: (RR-12).

Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, Gaynes R. Changes in the Epidemiology of Methicillin-Resistant Staphylococcus aureus in Intensive Care Units in US Hospitals, 1992–2003. Clin Infect Dis 2006; 42: 389–91.

Rattanaumpawan P, Thamlikitkul V, Chokepaibulkit K, Lohsiriwat D, Aswapokee N. Vancomycin overuse in Siriraj Hospital. J Med Assoc Thai 2006; 89 (Suppl 5): S125-32.

Junior MS, Correa L, Marra AR, Camargo LF, Pereira CA. Analysis of vancomycin use and associated risk factors in a university teaching hospital: a prospective cohort study. BMC Infectious Diseases 2007; 7: 88-93.

Centers for Disease Control and Prevention (CDC). Recommendations for Preventing the Spread of Vancomycin Resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Morbidity and Mortality Weekly Report (MMWR). (1995) 44: No. RR-12

Freifeld AG, Bows EJ, Sepkowitz KA, et al. Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Disease Society of America. Clin Infect Dis 2011; 52: 56-93.

Levy M, Koren G, Dupuis L, Read SE. Vancomycin-induced red man syndrome. Pediatrics 1990; 86(4): 572-80.

Hadaway L, Chamallas SN. Vancomycin: New Perspectives on an Old Drug. J Infus Nurs 2003; 26(5): 278-84.

Vance-Bryan K, Rotschafer JC, Gilliland SS, Rodvold KA, Fitzgerald CM, Guay DRP. A comparative assessment of vancomycin-associated nephrotoxicity in the young versus the elderly hospitalized patient. J Antimicrob Chemother 1994; 33: 811-21.

Published
2015-10-10
How to Cite
1.
Fahimi F, Soleymani F, Tavakoli-Ardakani M. Vancomycin Utilization Evaluation in a teaching hospital: A case- series study in Iran. J Pharm Care. 1(2):51-54.
Section
Original Article(s)